Bioptimus and Proscia Collaborate to Accelerate AI Innovation in Scientific Research and Drug Development for Improved Patient Care

Contributed by: Business Wire

Logo

Tags

Software

Research

Pharmaceutical

Oncology

Data Management

Technology

Artificial Intelligence

Health Technology

Science

Biotechnology

Other Science

Health

Proscia

More Like This

Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology

Bioptimus Launches H-optimus-0, the World's Largest Open-Source AI Foundation Model for Pathology

Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology

PR Newswire associated0

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress

Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery

insitro and UK’s INSIGHT at Moorfields Eye Hospital Announce Collaboration to Expand Research Efforts in Neurodegeneration and Related Conditions

PR Newswire associated0

Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions